Top

Published in:

01-04-2012 | Short Communication

Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis

Authors: Barbara Shih, Ardeshir Bayat

Published in: Archives of Dermatological Research | Issue 3/2012

Abstract

Keloid disease (KD) is a common fibroproliferative disorder that can occur following cutaneous injury in genetically susceptible individuals. Familial predisposition, high prevalence in certain populations and occurrence in twins suggest a strong genetic component to KD. However, to date no single causative gene has been identified. Copy number variations (CNVs) in genes have been associated with several human diseases including common skin disorders. The objective of this study was, therefore to determine if CNVs in the human genome may contribute to the development of KD. Agilent SurePrint G3 one Million microarrays were used to detect DNA copy number differences in keloid scars of four Caucasian females and compared to commercial reference DNA samples. Subsequent validation was performed with quantitative polymerase chain reactions (qPCR) using 15 KD cases and 27 Caucasian controls. Further validation using a second cohort was carried out with an additional 11 Caucasian controls and 10 KD cases developed from minor skin puncture wounds (caused by acne, vaccination or chickenpox). HLA-DRB1*15 was typed using allele-specific primers in PCR. Five CNV regions located at chromosome (chr) 6p21.32, chr11q11, chr17q12, chr8p23.1, chr22q13.1, chr19p13.1 and chr2q14.3 were selected for validation with qPCR. When comparing controls to subgroups of KD, according to their cause of scarring, chr6p21.32 (primer design targetting HLA-DRB5) was significantly (P < 0.005) associated with KD developed from minor skin puncture wounds, which is further validated using a larger sample size (P < 0.001). The presence of HLA-DRB5 was associated with HLA-DRB1*15 status; 18 out of 19 individuals were positive for both HLA-DRB5 and HLA-DRB1*15 allele. In conclusion, these preliminary findings further support the possible contribution of the HLA genes in KD pathogenesis.

Ashcroft KJ, Syed F, Arscott G, Bayat A (2011) Assessment of the influence of HLA class I and class II loci on the prevalence of keloid disease in Jamaican Afro-Caribbeans. Tissue Antigens (in press)

Beckmann JS, Estivill X, Antonarakis SE (2007) Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 8(8):639–646PubMedCrossRef

Berman B, Villa A (2003) Imiquimod 5% cream for keloid management. Dermatol Surg 29(10):1050–1051PubMedCrossRef

Bloom D (1956) Heredity of keloids: review of the literature and report of a family with multiple keloids in five generations. N Y State J Med 56(4):511–519PubMed

Bock O, Schmid-Ott G, Malewski P, Mrowietz U (2006) Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 297(10):433–438PubMedCrossRef

Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5(9):699–711PubMedCrossRef

Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG (2001) Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 54(6):511–516PubMedCrossRef

Brown JJ, Ollier WE, Thomson W, Bayat A (2008) Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 35(4–5):303–307PubMedCrossRef

Bunce M, O’Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI (1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46(5):355–367PubMedCrossRef

10.

Chen Y, Gao JH, Liu XJ, Yan X, Song M (2006) Characteristics of occurrence for Han Chinese familial keloids. Burns 32(8):1052–1059PubMedCrossRef

11.

Christen U, von Herrath MG (2004) Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 40(14–15):1113–1120PubMedCrossRef

12.

Clark JA, Turner ML, Howard L, Stanescu H, Kleta R, Kopp JB (2009) Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatol 9:8PubMedCrossRef

13.

Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79(3):439–448PubMedCrossRef

14.

Fong EP, Bay BH (2002) Keloids—the sebum hypothesis revisited. Med Hypotheses 58(4):264–269PubMedCrossRef

15.

Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L (2006) Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443(7111):574–577PubMed

16.

Gupta S, Sharma VK (2011) Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 77(1):94–100PubMedCrossRef

17.

Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40(1):23–25PubMedCrossRef

18.

Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ (2004) The UCSC Table Browser data retrieval tool. Nucl Acids Res. 32(Database issue):D493–D496

19.

Kazeem AA (1988) The immunological aspects of keloid tumor formation. J Surg Oncol 38(1):16–18PubMedCrossRef

20.

Lim CP, Phan TT, Lim IJ, Cao X (2009) Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts. J Invest Dermatol 129(4):851–861PubMedCrossRef

21.

Lu WS, Cai LQ, Wang ZX, Li Y, Wang JF, Xiao FL, Quan C, He SM, Yang S, Zhang XJ (2010) Association of HLA class I alleles with keloids in Chinese Han individuals. Hum Immunol 71(4):418–422PubMedCrossRef

22.

Lu WS, Wang JF, Yang S, Xiao FL, Quan C, Cheng H, Wang PG, Zhang AP, Cai LQ, Zhang XJ (2008) Association of HLA-DQA1 and DQB1 alleles with keloids in Chinese Hans. J Dermatol Sci 52(2):108–117PubMedCrossRef

23.

Lu WS, Zhang WY, Li Y, Wang ZX, Zuo XB, Cai LQ, Zhu F, Wang JF, Sun LD, Zhang XJ, Yang S (2010) Association of HLA-DRB1 alleles with keloids in Chinese Han individuals. Tissue Antigens 76(4):276–281PubMedCrossRef

24.

Lu WS, Zuo XB, Wang ZX, Cai LQ, Zhu F, Li Y, Zheng HF, Sun LD, Yang S, Zhang XJ (2011) Association of HLA haplotype with keloids in Chinese Hans. Burns

25.

Marneros AG, Norris JE, Olsen BR, Reichenberger E (2001) Clinical genetics of familial keloids. Arch Dermatol 137(11):1429–1434PubMed

26.

Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 122(5):1126–1132PubMedCrossRef

27.

Martin-Garcia RF, Busquets AC (2005) Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg 31(11 Pt 1):1394–1398PubMedCrossRef

28.

Melnikova I (2009) Psoriasis market. Nat Rev Drug Discov 8(10):767–768PubMedCrossRef

29.

Muller-Hilke B (2009) HLA class II and autoimmunity: epitope selection vs differential expression. Acta Histochem 111(4):379–381PubMedCrossRef

30.

Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T, Hosono N, Kubo M, Nakamura Y, Zembutsu H (2010) A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 42(9):768–771PubMedCrossRef

31.

Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9(7):516–526PubMedCrossRef

32.

Omo-Dare P (1975) Genetic studies on keloid. J Natl Med Assoc 67(6):428–432PubMed

33.

Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME (2006) Global variation in copy number in the human genome. Nature 444(7118):444–454PubMedCrossRef

34.

Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301(4):259–272PubMedCrossRef

35.

Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302(5):319–339PubMedCrossRef

36.

Walker MR, Nepom GT (2006) Major histocompatibility complex and autoimmunity. In: Rose NR, Mackay IR (eds) The autoimmune diseases. Elsevier, London, pp 47–58CrossRef

37.

Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman DE, MacAulay C, Ng RT, Brown CJ, Eichler EE, Lam WL (2007) A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 80(1):91–104PubMedCrossRef

38.

Xue H, McCauley RL, Zhang W (2000) Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 89(1):74–77PubMedCrossRef

39.

Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu Y, Kitzmiller K, Blanchong CA, McBride KL, Higgins GC, Rennebohm RM, Rice RR, Hackshaw KV, Roubey RA, Grossman JM, Tsao BP, Birmingham DJ, Rovin BH, Hebert LA, Yu CY (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80(6):1037–1054PubMedCrossRef

40.

Zhang J, Feuk L, Duggan GE, Khaja R, Scherer SW (2006) Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet Genome Res 115(3–4):205–214

Title: Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis
Authors: Barbara Shih
Ardeshir Bayat
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Archives of Dermatological Research / Issue 3/2012
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-011-1182-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Inflammatory peeling skin syndrome caused a novel mutation in CDSN

Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction

Reduced expression of microtubule-associated protein 1 light chain 3 in hypertrophic scars

Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis

Upcoming strategies for the treatment of metastatic melanoma

Osteopontin, a protein with cytokine-like properties: a possible involvement in pemphigus vulgaris